Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
abnobaVISCUM Fraxini in Superficial Bladder Cancer
NCT02007005Phase 2Completed
- Sponsor
- ABNOBA GmbH
- Start
- Jan 2004
- Primary completion
- Feb 2012
- Modality
- PE (Plant Extract)
- Countries
- 2
01
Overview
A Phase 2 trial of abnobaVISCUM Fraxini in bladder cancer, sponsored by ABNOBA GmbH. Started Jan 2004; status: completed.
02
Drugs
abnobaVISCUM Fraxini
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02007005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007005.